112 related articles for article (PubMed ID: 6873999)
21. Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus.
McDonald TL; Donnelly T; Weber A; Quenette L
Immunology; 1983 Mar; 48(3):511-7. PubMed ID: 6826202
[TBL] [Abstract][Full Text] [Related]
22. Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection.
Takei I; Asaba Y; Kasatani T; Maruyama T; Watanabe K; Yanagawa T; Saruta T; Ishii T
J Autoimmun; 1992 Dec; 5(6):665-73. PubMed ID: 1489482
[TBL] [Abstract][Full Text] [Related]
23. Lactic dehydrogenase virus (LDV) infection inhibits allergic eosinophil reaction in the airway.
Morimoto M; Ohji T; Iwata H; Hayashi T
Res Vet Sci; 2002 Apr; 72(2):131-6. PubMed ID: 12027593
[TBL] [Abstract][Full Text] [Related]
24. Exacerbation of murine malaria by concurrent infection with lactic dehydrogenase-elevating virus.
Henderson DC; Tosta CE; Wedderburn N
Clin Exp Immunol; 1978 Aug; 33(2):357-9. PubMed ID: 719954
[TBL] [Abstract][Full Text] [Related]
25. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
Weiland E; Weiland F; Grossmann A
J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
[TBL] [Abstract][Full Text] [Related]
26. Innate resistance to Listeria monocytogenes in tumor-bearing mice.
Gahan CG; Barrett JR; O'Brien MG; O'Sullivan GC; Shanahan F; Collins JK
J Leukoc Biol; 1997 Dec; 62(6):726-32. PubMed ID: 9400813
[TBL] [Abstract][Full Text] [Related]
27. Trojan Horse macrophages: studies with the murine lactate dehydrogenase-elevating virus and implications for sexually transmitted virus infection.
Cafruny WA; Bradley SE
J Gen Virol; 1996 Dec; 77 ( Pt 12)():3005-12. PubMed ID: 9000091
[TBL] [Abstract][Full Text] [Related]
28. Difference in neutralization between lactate dehydrogenase-elevating virus isolated from acutely and chronically infected mice.
Monteyne P; Coutelier JP
J Gen Virol; 1994 May; 75 ( Pt 5)():1173-6. PubMed ID: 8176379
[TBL] [Abstract][Full Text] [Related]
29. Correlation of extracts obtained by high efficiency gel chromatography of lactic dehydrogenase virus infected mouse serum and cytosol from human tumors using leukocyte adherence inhibition assay.
Jandová A; Mejsnarová B; Motycka K; Coupek J; Sanitrák J; Heyberger K; Pezlarová J
Neoplasma; 1979; 26(3):261-6. PubMed ID: 394008
[TBL] [Abstract][Full Text] [Related]
30. Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus.
Inada T; Mims CA
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1469-77. PubMed ID: 3860626
[TBL] [Abstract][Full Text] [Related]
31. Augmented nonspecific resistance and simultaneous impairment of specific immunity to Listeria monocytogenes in tumor-bearing mice.
Nomoto K; Mitsuyama M; Miake S; Yokokura T; Nomoto K
J Clin Lab Immunol; 1987 Oct; 24(2):75-9. PubMed ID: 3501807
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic T cells are elicited during acute infection of mice with lactate dehydrogenase-elevating virus but disappear during the chronic phase of infection.
Even C; Rowland RR; Plagemann PG
J Virol; 1995 Sep; 69(9):5666-76. PubMed ID: 7637013
[TBL] [Abstract][Full Text] [Related]
33. Lactic dehydrogenase virus alteration of lymphocyte circulation.
Mongini PK; Rosenberg LT
J Immunol; 1978 Feb; 120(2):459-62. PubMed ID: 621389
[TBL] [Abstract][Full Text] [Related]
34. Replication of lactate dehydrogenase-elevating virus in macrophages. 1. Evidence for cytocidal replication.
Ritzi DM; Holth M; Smith MS; Swart WJ; Cafruny WA; Plagemann GW; Stueckemann JA
J Gen Virol; 1982 Apr; 59(Pt 2):245-62. PubMed ID: 7077301
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of lymphocyte trapping by a passenger virus in murine ascitic tumors: characterization of lactic dehydrogenase virus (LDV) as the inhibitory component and analysis of the mechanism of inhibition.
Mongini PK; Rosenberg LT
J Exp Med; 1976 Jan; 143(1):100-13. PubMed ID: 1244415
[TBL] [Abstract][Full Text] [Related]
36. Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without interference with virus replication.
Harty JT; Chan SP; Contag CH; Plagemann PG
J Neuroimmunol; 1987 Jun; 15(2):195-206. PubMed ID: 3034974
[TBL] [Abstract][Full Text] [Related]
37. Isolation of Clq-binding virus-antibody immune complexes from lactic dehydrogenase virus (LDV)-infected mice.
McDonald TL
Immunology; 1982 Feb; 45(2):365-70. PubMed ID: 6977483
[TBL] [Abstract][Full Text] [Related]
38. Acute infection of mice with lactate dehydrogenase-elevating virus enhances Fc and complement receptor activity of peritoneal macrophages.
Lussenhop N; Holmes B; Cafruny WA; Plagemann PG
J Gen Virol; 1982 Jul; 61 (Pt l)():25-32. PubMed ID: 7119750
[TBL] [Abstract][Full Text] [Related]
39. Acute infection of mice with lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of their macrophages.
Isakov N; Feldman M; Segal S
Cell Immunol; 1982 Jan; 66(2):317-32. PubMed ID: 6461420
[No Abstract] [Full Text] [Related]
40. Glucocorticoid regulation of lactate dehydrogenase-elevating virus replication in macrophages.
Cafruny WA; Jones QA; Haven TR; Zitterkopf NL; Plagemann PG; Rowland RR
Virus Res; 2003 Mar; 92(1):83-7. PubMed ID: 12606079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
